前收市價 | 0.0100 |
開市 | 0.0100 |
買盤 | 0.0000 |
賣出價 | 0.5200 |
拍板 | 11.50 |
到期日 | 2024-05-31 |
今日波幅 | 0.0100 - 0.0100 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
Investors should not get overly excited about President Biden’s decision to reclassify marijuana. The potential move toward becoming a less dangerous schedule 3 drug is lengthy and will not result in cannabis becoming federally legal. That has important implications in relation to access to financing for cannabis firms among other things. This has led to investors considering if there are any cannabis stocks to sell as the road to Federal legalization is still long. Nothing has changed following
SolGel Technologies (SLGL) delivered earnings and revenue surprises of -53.33% and 64.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The company's cost-cutting initiative and pivot to medical cannabis could pay big dividends for patient shareholders.